Maze Therapeutics (MAZE) EV/EBITDA

EV/EBITDA

-9.83
+0.07+0.71%

Fri, 21 Feb 2025 14:30:00 GMT


Summary


Performance

MAZE EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherMAZEvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

MAZE EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+0.7%-0.8%-0.7%
6 m6 months---
1 y1 year---
5 y5 years---

MAZE EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-8.0%-12.57+21.8%
3 m3-month-9.10-8.0%-12.57+21.8%
6 m6-month-9.10-8.0%-12.57+21.8%
1 y1-year-9.10-8.0%-12.57+21.8%
3 y3-year-9.10-8.0%-12.57+21.8%
5 y5-year-9.10-8.0%-12.57+21.8%
alltimeall time-9.10-8.0%-12.57+21.8%

Maze Therapeutics EV/EBITDA History

DateValue
DateValue
2025
-9.83

FAQ

  • What is Maze Therapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Maze Therapeutics?

What is Maze Therapeutics EV/EBITDA?

The current EV/EBITDA of MAZE is -9.83

What is the all time high EV/EBITDA for Maze Therapeutics?

Maze Therapeutics all-time high EV/EBITDA is -9.10